BTC $78,976.72 -0.90%
ETH $2,479.31 -0.14%
BNB $739.57 -1.06%
XRP $1.39 -1.31%
SOL $103.72 -2.33%
TRX $0.3340 -0.38%
DOGE $0.0900 +0.95%
ADA $0.2208 +1.02%
BCH $267.17 +4.07%
LINK $12.92 +4.78%
HYPE $85.47 -3.19%
AAVE $132.00 -1.02%
SUI $0.8137 +1.47%
XLM $0.1923 +4.21%
ZEC $1,155.81 -1.96%
BTC $78,976.72 -0.90%
ETH $2,479.31 -0.14%
BNB $739.57 -1.06%
XRP $1.39 -1.31%
SOL $103.72 -2.33%
TRX $0.3340 -0.38%
DOGE $0.0900 +0.95%
ADA $0.2208 +1.02%
BCH $267.17 +4.07%
LINK $12.92 +4.78%
HYPE $85.47 -3.19%
AAVE $132.00 -1.02%
SUI $0.8137 +1.47%
XLM $0.1923 +4.21%
ZEC $1,155.81 -1.96%

Data: Pioneer Pharmaceutical Biotechnology surged over 240% during trading, having previously announced plans to acquire all shares of Conflux

2025-07-02 10:58:01

ChainCatcher news, Hong Kong listed company Pioneer Pharma Biotechnology (00399) saw a significant increase in trading volume this morning, with a peak rise of nearly 240%, reaching a maximum price of 0.7 HKD, before retreating to around 0.34 HKD.

Previously, the company announced plans to acquire 100% equity of the blockchain project Conflux to expand its presence in the blockchain field, with two founding members of Conflux currently serving as its executive directors.

app_icon
ChainCatcher Building the Web3 world with innovations.